Jaguar Health (JAGX)
1.33
+0.07 (5.56%)
Upcoming Events
Latest Headlines
Jaguar Health expands crofelemer compassionate use to EU infant
July 22, 2026 9:01 AM - StreetInsider
Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF) Due to Microvillus Inclusion Disease (MVID)
July 22, 2026 9:01 AM - StreetInsider
Jaguar Health (JAGX) files for 5.52M share offering by selling stockholders
July 16, 2026 6:04 AM - StreetInsider
Jaguar Health (JAGX) files for 40.8M share offering by selling stockholders
July 16, 2026 6:03 AM - StreetInsider
Form S-1 Jaguar Health, Inc.
July 16, 2026 6:01 AM - SEC Filing
Form S-1 Jaguar Health, Inc.
July 16, 2026 6:01 AM - SEC Filing
Form 8-K Jaguar Health, Inc. For: Jul 09
July 14, 2026 4:15 PM - SEC Filing
Form 8-K Jaguar Health, Inc. For: Jul 01
July 1, 2026 4:34 PM - SEC Filing
Form D Jaguar Health, Inc.
July 1, 2026 6:04 AM - SEC Filing
Form D Jaguar Health, Inc.
July 1, 2026 6:04 AM - SEC Filing
Jaguar Health crofelemer shows PS reductions in pediatric IF patients
June 30, 2026 9:04 AM - StreetInsider
Presentation at ESPGHAN 2026 Describes Additional Groundbreaking Results of Evaluation of Jaguar Health's Crofelemer as Adjunctive Oral Therapy for the Treatment of Pediatric Intestinal Failure (IF)
June 30, 2026 9:01 AM - StreetInsider
Life Sciences Virtual Investor Forum Presentations Now Available for On-Demand Viewing
June 26, 2026 8:35 AM - StreetInsider
Form 8-K Jaguar Health, Inc. For: Jun 22
June 25, 2026 9:16 AM - SEC Filing
Jaguar Health Announces Conversion of Series O Convertible Preferred Stock Issued as Recent One-time Stock Dividend
June 25, 2026 9:01 AM - StreetInsider
Jaguar Health files for full FDA approval of dog diarrhea drug
June 23, 2026 9:01 AM - StreetInsider
Jaguar Health Completes Submission of New Animal Drug Application for Full FDA Approval of Crofelemer for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs
June 23, 2026 9:01 AM - StreetInsider
Life Sciences Virtual Investor Forum Agenda Announced for June 24th & 25th
June 23, 2026 8:35 AM - Globe NewsWire
Life Sciences Virtual Investor Forum Agenda Announced for June 24th & 25th
June 23, 2026 8:35 AM - StreetInsider
Form 8-K/A Jaguar Health, Inc. For: Jun 22
June 22, 2026 4:26 PM - SEC Filing
Form 8-K Jaguar Health, Inc. For: Jun 22
June 22, 2026 9:17 AM - SEC Filing
Jaguar Health explores strategic alternatives amid rare disease NDA push
June 22, 2026 9:00 AM - StreetInsider
Jaguar Health Announces Plan to Explore Strategic Alternatives Aligned with Targeted NDA Filing for Rare Disease Intestinal Failure Program
June 22, 2026 9:00 AM - StreetInsider
Form 8-K Jaguar Health, Inc. For: Jun 17
June 18, 2026 5:16 PM - SEC Filing
Red Light Holland reports preclinical coca extract results for post-GLP-1 weight management
June 18, 2026 9:03 AM - StreetInsider
Red Light Holland Reports Positive Preclinical Study Results for Coca in Weight Gain Prevention Post GLP-1 from Magdalena Biosciences, the Joint Venture Held Through Its Wholly Owned Subsidiary, Filam
June 18, 2026 9:03 AM - StreetInsider
Magdalena Biosciences coca extract prevents weight gain in mice
June 18, 2026 9:01 AM - StreetInsider
Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, Announces Positive Results of Preclinical Study of Coca for Weight Gain Prevention
June 18, 2026 9:01 AM - StreetInsider
Jaguar Health Presenting June 24, 2026 at the Life Sciences Virtual Investor Forum to Provide Updates on Company's Crofelemer Development Program for Rare Intestinal Failure Diseases
June 12, 2026 9:01 AM - StreetInsider
Form 8-K Jaguar Health, Inc. For: Jun 08
June 11, 2026 9:01 AM - SEC Filing
Presenting on Emerging Growth Conference 93 Day 1 on June 10; Register to live stream
June 9, 2026 7:00 AM - Globe NewsWire
Form 8-K Jaguar Health, Inc. For: Jun 08
June 8, 2026 4:41 PM - SEC Filing
Jaguar Health reports stockholder approval of all annual meeting proposals
June 8, 2026 4:16 PM - StreetInsider
Jaguar Health Reports Approval of All Proposals at 2026 Annual Meeting of Stockholders
June 8, 2026 4:15 PM - StreetInsider
Form 8-K Jaguar Health, Inc. For: Jun 01
June 2, 2026 4:10 PM - SEC Filing
Form DEFA14A Jaguar Health, Inc.
May 29, 2026 5:24 PM - SEC Filing
Jaguar Health advances crofelemer development for rare gastrointestinal disorders
May 28, 2026 10:02 AM - StreetInsider
Jaguar Health Research in Ethnobotanical Medicine Helps Advance Crofelemer Development for Genetically Defined Rare Congenital Gastrointestinal Disorders
May 28, 2026 10:00 AM - StreetInsider
Form 8-K Jaguar Health, Inc. For: May 26
May 27, 2026 9:10 AM - SEC Filing
Jaguar Health regains compliance with NASDAQ bid price rule
May 27, 2026 9:01 AM - StreetInsider
Jaguar Health Compliant with Nasdaq Bid Price Rule
May 27, 2026 9:01 AM - StreetInsider
Form 8-K Jaguar Health, Inc. For: May 21
May 22, 2026 5:23 PM - SEC Filing
Jaguar Health (JAGX) Misses Q1 EPS by 1360c
May 21, 2026 11:10 AM - StreetInsider
Jaguar Health Reports First Quarter 2026 Financials
May 20, 2026 4:40 PM - StreetInsider
Form 8-K Jaguar Health, Inc. For: May 20
May 20, 2026 4:36 PM - SEC Filing
Form 10-Q Jaguar Health, Inc. For: Mar 31
May 20, 2026 4:07 PM - SEC Filing
Jaguar Health to Hold Investor Webcast May 26 Regarding Q1 2026 Financials & Corporate Updates; Jaguar CEO Lisa Conte Presenting May 28 at Lytham Partners Spring 2026 Investor Conference
May 20, 2026 9:04 AM - StreetInsider
Form 8-K Jaguar Health, Inc. For: May 19
May 19, 2026 5:07 PM - SEC Filing
Jaguar Health advances MVID drug trial to extension phase
May 19, 2026 9:04 AM - StreetInsider
Jaguar Health Announces Active Treatment Only Continuation of Pivotal Multicenter Clinical Trial in Pediatric Patients with Microvillus Inclusion Disease (MVID) to Support a New Drug Application (NDA)
May 19, 2026 9:02 AM - StreetInsider
Form NT 10-Q Jaguar Health, Inc. For: Mar 31
May 18, 2026 3:06 PM - SEC Filing
Jaguar Health regains NASDAQ compliance, gets extension to meet bid price rule
May 8, 2026 9:01 AM - StreetInsider
Jaguar Health Regains Compliance with Nasdaq's Publicly Held Shares Requirement and Receives Additional Extension, Until May 18, 2026, to Demonstrate Compliance with Nasdaq's Bid Price Rule
May 8, 2026 9:01 AM - StreetInsider
Form 8-K Jaguar Health, Inc. For: May 06
May 7, 2026 2:59 PM - SEC Filing
Jaguar Health discusses FDA breakthrough therapy designation for rare disease treatment
May 6, 2026 9:01 AM - StreetInsider
Jaguar Health Announces Preliminary Discussion with FDA to Evaluate Breakthrough Therapy Designation for Crofelemer for Treatment of Microvillus Inclusion Disease (MVID)
May 6, 2026 9:00 AM - StreetInsider
Form DEFA14A Jaguar Health, Inc.
May 6, 2026 8:00 AM - SEC Filing
Form 8-K Jaguar Health, Inc. For: May 04
May 4, 2026 5:10 PM - SEC Filing
Jaguar Health launches Neonorm Dog for canine digestive health
May 4, 2026 8:31 AM - StreetInsider
Jaguar Health Expands Neonorm Franchise with Introduction of Neonorm Dog for Companion Animal Gut Health
May 4, 2026 8:30 AM - StreetInsider
Form 8-K Jaguar Health, Inc. For: May 01
May 4, 2026 8:00 AM - SEC Filing
Form DEF 14A Jaguar Health, Inc. For: May 22
April 30, 2026 10:13 AM - SEC Filing
Form ARS Jaguar Health, Inc. For: Dec 31
April 30, 2026 6:06 AM - SEC Filing
Jaguar Health Announces Statistically Significant Results from Effectiveness Trial of Crofelemer (FDA Approved Canalevia-CA1) for Treatment of Chemotherapy-Induced Diarrhea in Dogs
April 29, 2026 8:36 AM - StreetInsider
Form 8-K Jaguar Health, Inc. For: Apr 24
April 27, 2026 9:10 AM - SEC Filing
Jaguar Health gets nasdaq extension, plans 1-for-35 reverse stock split
April 27, 2026 9:08 AM - StreetInsider
Jaguar Health Granted Extension Until May 15, 2026, to Demonstrate Compliance with Nasdaq's Bid Price Rule; Company Announces Reverse Stock Split
April 27, 2026 9:07 AM - StreetInsider
Jaguar Health Announces Acceptance of two Late-Breaking Abstracts for Liquid Oral Crofelemer Treatment of Intestinal Failure in Pediatric Patients at the European Society for Pediatric Gastroenterolog
April 24, 2026 8:35 AM - StreetInsider
Full Article List
